We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.22%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$666B
AUM Growth
+$8.72B
Cap. Flow
+$1.57B
Cap. Flow %
0.24%
Top 10 Hldgs %
22.76%
Holding
14,701
New
2,078
Increased
5,000
Reduced
5,362
Closed
2,191

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$775M
2
ABBV icon
AbbVie
ABBV
+$540M
3
DAL icon
Delta Air Lines
DAL
+$434M
4
LLY icon
Eli Lilly
LLY
+$433M
5
DXCM icon
DexCom
DXCM
+$433M

Sector Composition

Rank Sector Weight
1 Technology 4.89%
2 Healthcare 2.92%
3 Financials 2.71%
4 Consumer Discretionary 2.52%
5 Industrials 2.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLG
11126
PUT
Platinum Group Metals
PLG
$189M
$173K ﹤0.01%
73,100
+56,100
+330% +$135K
GPRO icon
11127
PUT
GoPro
GPRO
$110M
$172K ﹤0.01%
122,300
-137,000
-53% -$249K
CRNT icon
11128
Ceragon Networks
CRNT
$200M
$172K ﹤0.01%
82,083
-449,658
-85% -$1M
GOOY icon
11129
PUT
YieldMax GOOGL Option Income Strategy ETF
GOOY
$231M
$172K ﹤0.01%
11,800
-9,600
-45% -$139K
TLX
11130
Telix Pharmaceuticals
TLX
$4B
$172K ﹤0.01%
+22,998
New +$221K
SOLZ
11131
Solana ETF
SOLZ
$86.9M
$172K ﹤0.01%
+13,492
New +$226K
NDLS icon
11132
Noodles & Co
NDLS
$107M
$172K ﹤0.01%
+30,377
New +$173K
CCLD icon
11133
PUT
CareCloud
CCLD
$110M
$171K ﹤0.01%
+58,700
New +$186K
TXG icon
11134
PUT
10x Genomics
TXG
$7.31B
$171K ﹤0.01%
10,500
-33,500
-76% -$506K
CMMB
11135
Chemomab Therapeutics
CMMB
$14M
$171K ﹤0.01%
+103,781
New +$275K
RAVE icon
11136
RAVE Restaurant Group
RAVE
$43.2M
$171K ﹤0.01%
51,862
+26,712
+106% +$77.3K
SJT
11137
CALL
San Juan Basin Royalty Trust
SJT
$131M
$171K ﹤0.01%
30,400
-158,400
-84% -$917K
CANE icon
11138
Teucrium Sugar Fund
CANE
$53.5M
$171K ﹤0.01%
17,500
+2,615
+18% +$25.3K
NOTE
11139
DELISTED
FiscalNote
NOTE
$170K ﹤0.01%
+115,934
New +$352K
KIO
11140
KKR Income Opportunities Fund
KIO
$456M
$170K ﹤0.01%
+14,703
New +$174K
WDH
11141
Waterdrop
WDH
$359M
$170K ﹤0.01%
+89,675
New +$160K
SPRO icon
11142
PUT
Spero Therapeutics
SPRO
$71.6M
$170K ﹤0.01%
73,100
+18,300
+33% +$42.5K
CXDO icon
11143
PUT
Crexendo
CXDO
$221M
$170K ﹤0.01%
26,300
-6,100
-19% -$39.9K
BSM icon
11144
CALL
Black Stone Minerals
BSM
$3.05B
$170K ﹤0.01%
12,800
-17,000
-57% -$230K
NNY icon
11145
Nuveen New York Municipal Value Fund
NNY
$157M
$170K ﹤0.01%
19,805
+7,880
+66% +$66.6K
RLMD icon
11146
CALL
Relmada Therapeutics
RLMD
$512M
$170K ﹤0.01%
35,100
+16,800
+92% +$56.3K
LX
11147
PUT
LexinFintech Holdings
LX
$224M
$169K ﹤0.01%
51,600
+8,600
+20% +$35.3K
RGNX icon
11148
CALL
Regenxbio
RGNX
$711M
$168K ﹤0.01%
11,700
-5,000
-30% -$62.3K
GTN icon
11149
CALL
Gray Television
GTN
$538M
$168K ﹤0.01%
34,800
-332,900
-91% -$1.63M
HRZN icon
11150
PUT
Horizon Technology Finance
HRZN
$336M
$168K ﹤0.01%
26,100
+3,100
+13% +$19.8K

Similar funds

Ken Griffin's Q4 2025 Portfolio in Review

As of Q4 2025, Ken Griffin held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Ken Griffin's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,362 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.

By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.

  • Ken Griffin's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
  • Ken Griffin added most to Amazon in Q4 2025, an estimated $2.49B increase.
  • Ken Griffin's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
  • Ken Griffin fully exited WEX in Q4 2025, selling an estimated $131M.
  • Ken Griffin's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
  • Ken Griffin opened 2,078 new positions and closed 2,191 in Q4 2025.
  • Ken Griffin's portfolio value rose 1.3% quarter-over-quarter to $666B.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.